BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30402041)

  • 21. Prognostic significance of urokinase plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in lymph node- and hormone receptor-positive breast cancer.
    Leissner P; Verjat T; Bachelot T; Paye M; Krause A; Puisieux A; Mougin B
    BMC Cancer; 2006 Aug; 6():216. PubMed ID: 16945123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasminogen activator system in human coronary atherosclerosis.
    Raghunath PN; Tomaszewski JE; Brady ST; Caron RJ; Okada SS; Barnathan ES
    Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1432-43. PubMed ID: 7670959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential regulation by troglitazone of plasminogen activator inhibitor type 1 in human hepatic and vascular cells.
    Nordt TK; Peter K; Bode C; Sobel BE
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1563-8. PubMed ID: 10770198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasminogen activator inhibitor type 1 is increased in the arterial wall of type II diabetic subjects.
    Pandolfi A; Cetrullo D; Polishuck R; Alberta MM; Calafiore A; Pellegrini G; Vitacolonna E; Capani F; Consoli A
    Arterioscler Thromb Vasc Biol; 2001 Aug; 21(8):1378-82. PubMed ID: 11498469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistin is secreted from macrophages in atheromas and promotes atherosclerosis.
    Jung HS; Park KH; Cho YM; Chung SS; Cho HJ; Cho SY; Kim SJ; Kim SY; Lee HK; Park KS
    Cardiovasc Res; 2006 Jan; 69(1):76-85. PubMed ID: 16271710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries.
    Lupu F; Bergonzelli GE; Heim DA; Cousin E; Genton CY; Bachmann F; Kruithof EK
    Arterioscler Thromb; 1993 Jul; 13(7):1090-100. PubMed ID: 7686395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of plasminogen activator inhibitor-1 is a potential therapeutic strategy in ovarian cancer.
    Mashiko S; Kitatani K; Toyoshima M; Ichimura A; Dan T; Usui T; Ishibashi M; Shigeta S; Nagase S; Miyata T; Yaegashi N
    Cancer Biol Ther; 2015; 16(2):253-60. PubMed ID: 25587663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behaviour of tissue plasminogen activator, plasminogen activator inhibitor 1 and their complex in various disease states.
    Niwano H; Takahashi H; Tatewaki W; Wada K; Seki Y; Shibata A
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):389-93. PubMed ID: 1420814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-associated proteolysis and prognosis: new functional risk factors in gastric cancer defined by the urokinase-type plasminogen activator system.
    Heiss MM; Babic R; Allgayer H; Gruetzner KU; Jauch KW; Loehrs U; Schildberg FW
    J Clin Oncol; 1995 Aug; 13(8):2084-93. PubMed ID: 7636552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The plasma levels of transforming growth factor beta1 and the protein expressions of alpha-SMA, urokinase plasminogen activator and plasminogen activator inhibitor-1 in liver of patients with different grades of hepatic fibrosis].
    Wu XR; Lv MH; Wang Q; Shi SS; Guo WD
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):400-2. PubMed ID: 15268802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered expression of urokinase-type plasminogen activator and plasminogen activator inhibitor in high-risk soft tissue sarcomas.
    Benassi MS; Ponticelli F; Azzoni E; Gamberi G; Pazzaglia L; Chiechi A; Conti A; Spessotto P; Scapolan M; Pignotti E; Bacchini P; Picci P
    Histol Histopathol; 2007 Sep; 22(9):1017-24. PubMed ID: 17523079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor stroma is the predominant uPA-, uPAR-, PAI-1-expressing tissue in human breast cancer: prognostic impact.
    Hildenbrand R; Schaaf A; Dorn-Beineke A; Allgayer H; Sütterlin M; Marx A; Stroebel P
    Histol Histopathol; 2009 Jul; 24(7):869-77. PubMed ID: 19475533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dexamethasone increased plasminogen activator inhibitor-1 expression on human umbilical vein endothelial cells: an additive effect to tumor necrosis factor-alpha.
    Yamamoto Y; Ishizu A; Ikeda H; Otsuka N; Yoshiki T
    Pathobiology; 2004; 71(6):295-301. PubMed ID: 15627839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor.
    Zheng Q; Tang ZY; Xue Q; Shi DR; Song HY; Tang HB
    J Cancer Res Clin Oncol; 2000 Nov; 126(11):641-6. PubMed ID: 11079728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Higher levels of urokinase plasminogen activator system components in the airways of chronic obstructive pulmonary disease patients].
    Xiao W; Tong WL; Ma DD
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Nov; 29(11):723-6. PubMed ID: 17327049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of urokinase type plasminogen activator and plasminogen activator inhibitor-1 expressions on the formation of aneurysm of perimembranous ventricular septal defect].
    Qian J; Li B; Yin M; Shen P; Sun K
    Zhonghua Er Ke Za Zhi; 2015 Jun; 53(6):453-8. PubMed ID: 26310557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased intramural expression of plasminogen activator inhibitor type 1 after balloon injury: a potential progenitor of restenosis.
    Sawa H; Lundgren C; Sobel BE; Fujii S
    J Am Coll Cardiol; 1994 Dec; 24(7):1742-8. PubMed ID: 7963123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 (PAI-1) expression in human colorectal carcinomas.
    Papadopoulou S; Scorilas A; Yotis J; Arnogianaki N; Plataniotis G; Agnanti N; Talieri M
    Tumour Biol; 2002; 23(3):170-8. PubMed ID: 12218297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human fibroblasts downregulate plasminogen activator inhibitor type-1 in cultured human macrovascular and microvascular endothelial cells.
    Zhang JC; Fabry A; Paucz L; Wojta J; Binder BR
    Blood; 1996 Nov; 88(10):3880-6. PubMed ID: 8916953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of plasminogen activator inhibitor-1 expression by siRNA in rat hepatic stellate cells.
    Hu PF; Zhu YW; Zhong W; Chen YX; Lin Y; Zhang X; Yin C; Yue HY; Xie WF
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1917-25. PubMed ID: 18761555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.